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Campylobacter jejuni and Campylobacter coli are the most common cause of bacterial 
gastroenteritis, affecting approximately 96 million people around the world every year. 
Campylobacteriosis is characterized by diarrhoea, abrupt abdominal pain, and fever. 
Generally, the disease is self-limiting and resolves within a few days. Occasionally, 
neurological symptoms manifest clinically three weeks post-infection, indicating the onset 
of Guillain-Barré syndrome (GBS). GBS is a polyradiculoneuropathy characterized by an 
acute progressive and symmetrical motor weakness of the extremities with varying degrees 
of areflexia. 
GBS has been established as a post-infectious sequelae, whose principal aetiological agent 
is C. jejuni. The C. jejuni-GBS link was the first confirmed case of human autoimmune 
disease caused by ganglioside mimicry. C. jejuni lipooligosaccharides (LOS) have been 
established as the main structure responsible for ganglioside mimicry. 
Studies on the genetic basis of ganglioside-like LOS expression in C. jejuni have identified 
the genes associated with the addition of sialic acid (Neu5Ac) to the LOS chain; neuA, neuB, 
neuC, and a gene encoding a sialyltransferase from the glycosyltransferase CAZy family 42 
(GT-42). These genes are found within the LOS biosynthesis locus of C. jejuni. The 
existence of neuA, neuB, neuC, and GT-42 genes in C. coli is unknown, despite the fact that 
this species has also been isolated from GBS patients.  
The primary aim of this study was to investigate the diversity of the C. coli LOS biosynthesis 
locus with particular interest in identifying genetic features associated with the synthesis 
and transfer of Neu5Ac. C. coli was found to possess a more diverse LOS biosynthesis locus 
than previously thought. A total of 27 different LOS locus classes containing a GT-42 
encoding gene were identified. Among these, 16 are potentially able to synthesize sialylated 
LOS structures. Interestingly, several LOS locus classes resemble those of C. jejuni 
involved in ganglioside mimicry. Thus, bacterial factors implicated in GBS aetiology can 
cross species barriers. Also, C. coli has a larger GT-42 enzyme repertoire than C. jejuni. 
Two of the most common GT-42 encoding genes in C. coli were found to be associated to 
the presence of nonulosonic acid in LOS structures. Marked differences in diversity in the 
LOS locus were observed between C. coli clades, suggesting a potential role of this 
structures in niche adaptation. The importance of LOS to C. coli ecology and host-pathogen 
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1 INTRODUCTION  
In nature, there are four major classes of macromolecules: lipids, DNA, proteins, and 
carbohydrates. In recent years, the importance of sugars and glycoconjugates for the biology 
of diverse organisms has come to light. Glycobiology, a term devised in 1988 by Raymond 
Dwek, is an expanding field involving the study of carbohydrates in a biological setting (1). 
Among living organisms, bacteria synthesize a wide range of complex sugars which is about 
six times more diverse than what is found in eukaryotes. Since sugars are located on surface 
structures, they frequently play a role in cell-host interaction and serve as a first line of 
defence against the harsh environment. In fact, pathogens which lack classical virulence 
factors may heavily rely on glycoconjugate structures to modulate the host immune response 
(2). Such is the case of the Gram-negative, microaerobic, nonfermenter, nonsporeformer 
Campylobacter spp. Campylobacter jejuni and Campylobacter coli are common cause of 
bacterial gastroenteritis in the world, accounting for approximately 96 million cases every 
year (3). Given the fundamental role of glycans in the biology and pathogenesis of C. jejuni 
and C. coli (4, 5), approximately 10% of the genome is estimated to encode 
glycosyltransferases and other enzymes involved in the synthesis and modification of sugar 
nucleotides (6). The lipooligosaccharide (LOS) biosynthesis locus is one of the four major 
glycan biosynthesis loci. As the name suggests, genes within this locus are involved in the 
biosynthesis of LOS structures. Research on the genetic diversity of the LOS biosynthesis 
locus has been driven by the ability of C. jejuni to express LOS structures resembling human 
glycans, particularly gangliosides (7-10). Occasionally, infection with a C. jejuni strain 
expressing ganglioside-like LOS may trigger the development an autoimmune disease 
known as Guillian-Barré syndrome (GBS) (11). According to estimates, between 28-45% 
of GBS cases are due to Campylobacter infection (3). Genes involved in synthesis (neuA, 
neuB1, and neuC) and transfer (glycosyltransferases from the CAzy family 42 (GT-42) (12)) 
of sialic acid (Neu5Ac) are essential for the expression of ganglioside mimics in C. jejuni. 
So far, these genes have been found in the C. jejuni LOS biosynthesis locus genetic classes 
A, B, C, M, R, or V. All studied C. jejuni strains carrying one of these classes have been 
shown to express ganglioside mimics, among other sialylated LOS structures. In few 
instances, C. coli has also been isolated from GBS patients (13-16). However, the 
overrepresentation of C. jejuni and the deceptive overlap that this two species have in 
ecology, epidemiology, and pathogenesis has resulted in C. coli being vastly neglected. No 
classes containing genes involved in LOS sialylation were identified in the single study 
addressing C. coli LOS locus diversity (17). Moreover, excluding a single C. coli strain (16), 
no LOS sialylation has been found in the few studied C. coli strains (18-22). Thus, the scarce 
research conducted so far, is insufficient to determine whether a link between C. coli and 
GBS exists. In this study the origin, evolution, and distribution of the molecular machinery 
for biosynthesis of sialylated LOS structures in Campylobacter coli is addressed. 
Additionally, insights into the function of cstIV and cstV, the most common C. coli LOS 




2 REVIEW OF THE LITERATURE 
2.1 The importance of Campylobacter spp.  
Campylobacter spp. are Gram-negative, microaerobic, nonsaccharolytic bacteria which are 
the most common cause of bacterial gastroenteritis worldwide. According to WHO 
estimates, Campylobacter spp. accounted for approximately 27% (96 million cases) of 
foodborne illness in 2010 (Fig. 1) (3).  
 
Figure 1. Median global number of cases in millions of bacterial foodborne illnesses in 2010. Campylobacter 
spp. bar represents estimated number of C. jejuni (light grey) and C. coli (dark grey) cases Source: (3)  
In general campylobacteriosis is an acute gastroenteritis disease characterized by abrupt 
abdominal pain, diarrhoea ranging from watery to bloody, fever, and headache (23). The 
disease is frequently self-limiting, resolving typically within ten days and with a very low-
mortality rate (3, 24). However, in some cases post-infection complications, such as the 
Guillain-Barré syndrome (GBS), may occur. In poliomyelitis-free countries, GBS is the 
most common form of acute neuromuscular paralysis (25, 26). In 2010 around 100 000 
campylobacteriosis patients (or ~0.1% of the gastroenteritis cases) developed GBS three 
weeks after Campylobacter infection (27-29), implicating that between 28-45% of GBS 
cases are due to Campylobacter infection (3). As a result, among the most common 
foodborne diarrhoeal disease agents, Campylobacter spp. was the leading cause of years 






























Figure 2. Median global number of YLDs of bacterial foodborne illnesses in 2010. Source: (3)  
2.1.1 Campylobacter spp. and GBS 
GBS is an atypical autoimmune disease, first described by G. Guillain and J. A. Barré in 
1916 (30). In general, GBS is a polyradiculoneuropathy characterized by an acute 
progressive and symmetrical motor weakness of the extremities with varying degrees of 
areflexia. Additionally, clear patient-to-patient variation has given rise to GBS subforms 
such as the Miller Fisher syndrome (MFS) (25, 31). Although GBS was promptly 
recognized as a post-infectious disease, the aetiological agent remained unknown until 1982 
when C. jejuni was first isolated from a GBS patient stool (32). Further immunochemical 
and nuclear magnetic resonance (NMR) studies on C. jejuni (33-35) and reproduction of the 
disease in animal models (36-38) established C. jejuni-GBS as the first confirmed case of 
human autoimmune disease caused by ganglioside mimicry. Gangliosides are glycolipids 
primarily found in the nervous system and generally anchored in the external leaflet of the 
lipid bilayer by a ceramide moiety, while extracellularly exposing a highly variable 
sialylated oligosaccharide moiety (39). 
Campylobacter sialylated glycoconjugates have been established as the main structures 
responsible for the mimicry (11, 38, 40, 41). The vast majority of neuropathogenic 
Campylobacter isolates express variable glycoconjugate structures, resulting in the 
production of more than one type of antiganglioside antibodies by the patients (42). At the 
acute stage of GBS, high titres of more than 20 different anti-ganglioside antibodies have 
been identified. Among those, antibodies against LM1, GM1, GM1b, GM2, GD1a, GalNac-
GD1a, GD1b, GD2, GD3, GT1a, and GQ1b gangliosides are the most frequently 
encountered (8, 36, 41, 43-45). Despite the clear implication of ganglioside mimicry in the 
pathogenesis of Campylobacter-associated GBS/MFS, strains expressing ganglioside-like 

































background and immunological status may play an important role in the development of the 
disease (8, 9, 46). 
2.2 C. jejuni and C. coli population structure and source attribution 
The Campylobacter genus is currently comprised of 29 species that have been isolated from 
various species of wild and domesticated birds, mammals, and reptiles. Some 
Campylobacter species are human pathogens (47, 48). Among them, C. jejuni is the most 
frequently isolated species from human patients (~80-97%), followed by C. coli (~3-20%) 
(49-55). C. jejuni and C. coli are genetically closely related, and seemingly share similar 
niches, epidemiology, and risk factors (50, 56). The overrepresentation of C. jejuni and the 
apparent overlap between the two species has resulted in C. coli being vastly neglected in 
Campylobacter research. Yet, the number of C. coli infections surpasses that of other major 
pathogens (3, 54) (Fig. 1). Recent studies on aetiology (49, 50, 55, 57), epidemiology (53, 
58), and genetics (59-62) have shown that C. jejuni and C. coli are more different than 
previously thought (63, 64). Additionally, C. jejuni and C. coli exhibit distinct population 
structures, as shown by multilocus sequence typing (MLST) data (63-69). MLST is a 
molecular typing method based on sequence variability of seven unlinked chromosomal 
loci-encoding genes belonging to the core genome, which are not subject to positive section 
and that in fact demonstrate selection against amino acid substitution (68, 69). The method 
assigns an allele number to distinct sequences at each locus. A sequence type (ST) is defined 
as a unique combination of allelic variants (70). STs that occupy a central position in a 
population are defined as central genotypes (67, 71). ST groups sharing at least four 
identical alleles with a central genotype are grouped into a clonal complex (CC). 
Conversely, a ST that cannot be allocated to a group is considered to be a singleton. 
A key aspect of C. jejuni and C. coli ecology is their ability to colonize multiple hosts (72-
76). However, the relationship between host niche and lineage structure in these two species 
is considerably different (65, 66, 74, 75). C. jejuni population is weakly clonal and currently 
structured into 44 CCs (https://pubmlst.org/campylobacter/ as of May 2017). In general, C. 
jejuni population structure is shaped by niche (i.e. host) segregation. The most evident 
segregation has been described in wild birds, as only 1% of wild birds STs occur in more 
than one species (74, 75, 77). Furthermore, C. jejuni populations from closely taxonomically 
related hosts showed low levels of genetic differentiation in MLST genes despite geographic 
origin (74). Similarly, host-association in agricultural related strains appears to be stronger 
than phylogeography (78). Some lineages, such as ST-257 and ST-61 CC, exhibited gradual 
divergence due to host specialization (75, 78, 79). However, the genotype-host association 
is weaker in farmed animals in comparison to wild birds (75, 78, 79). A large proportion of 
isolated strains from agricultural sources belong to CCs with a broad host range, thus, these 
CCs are considered to be host generalist (75, 79-82). ST-21 and ST-45 CCs are two of the 
most common generalist CCs isolated worldwide (81, 83, 84). Their ubiquity and rapid host 
jump hamper source attribution efforts and phylogenetic associations (82). 
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C. coli was originally considered to be less variable than C. jejuni according to MLST 
analysis (59, 69, 85). Early studies found that the majority of C. coli (~98%) belonged to 
two related clonal lineages (59, 85). Nevertheless, these studies had solely focused on 
MLST diversity in agricultural associated C. coli. Typing of C. coli from larger and more 
diverse isolate collections revealed that C. coli population is remarkably different from C. 
jejuni, as it is divided into three deep branched clades, containing a total of five distinct 
lineages (63, 64, 66, 67, 84, 86). Clade 1, encompassing clusters A, B, and C (C1-A, C1-B, 
C1-C) is primarily associated with agriculture. Meanwhile, clades 2 and 3 are mainly 
associated with waterfowl and environmental sources (63, 66, 86). Hence, the genetic 
substructure of C. coli is related to ecology rather than host. Furthermore, maintenance of a 
3-deeply branched clade population structure and the relatively inexistence of horizontal 
gene transfer (HGT) between clades suggests three distinct genetic pools (63, 64, 66, 87).  
Only two CCs have been defined in C. coli clade 1 to date; ST-828 (C1-A) and ST-1150 
(C1-B). ST-828 is by far the most abundant CC representing 60-80% of genotyped isolates, 
while ~2% of the isolates belong to ST-1150 CC (67, 84, 86). Clade 1 shows evidence of 
recent clonal descent, and is characterised by low synonymous sequence variation at MLST 
loci and heavy reliance on recombination to generate diversity (63). Recombination in this 
clade transcends species, as studies have shown a recent increase in asymmetric gene flow 
between C. coli C1-A and C1-B and agricultural C. jejuni, possibly enhanced by co-
colonization of agricultural hosts (63, 66, 87). Introgression of C. coli C1-A and C1-B with 
the so called agricultural C. jejuni population has resulted in whole-allele replacement (63) 
and occurrence of mosaic alleles (87) in housekeeping genes. Additionally, large 
proportions of the genetic material throughout the genomes of C1-A (9.7-11.2%) and C1-B 
(20.4-22.5%) isolates have been shown to be imported from agricultural C. jejuni strains 
(66). This level of introgression has resulted in an average of 9.8 protein coding differences 
per gene (66). Moreover, if levels of genetic import from agricultural C. jejuni remain high, 
C. coli C1-A and C1-B may potentially converge or despeciate (63, 66). 
Although the exact impact of C. coli clade 1 introgression on agricultural niche adaptation 
is yet to be studied, the apparent absence of unintrogressed C. coli (C-2 and C-3) in farm 
animals has prompted speculation that import of C. jejuni DNA has been crucial for 
transmission, adaptation, and proliferation in this niche (66). For example, introgression has 
resulted in an increase in C. coli ST-828 CC pan genome size due to the acquisition of new 
metabolic pathways. Some of these pathways have been shown to provide colonization 
advantages in C. jejuni (66, 88). Yet, C. coli ST-828 genome has a smaller number of 
accessory genes in comparison to C. jejuni generalist ST-21 and ST-45 CCs, thus, 
suggesting more restricted metabolic capabilities (82). This limited metabolic plasticity is 
apparent by C. coli ST-828 CC estimated lower migration rate and zoonotic transmission; 
one hosts jump every 12 years and lower host switching frequency between mammals and 
chicken (82). Conversely, C. jejuni ST-21 and ST-45 CCs are predicted to jump hosts every 
1.6 or 1.8 years, respectively, and show homogeneity in the relative rates of transmission 
between host species (82).     
Although C. coli human infections are mainly associated with agricultural sources (53, 64, 
89-91), a recent study found clade 3 strains to be overrepresented in clinical isolates (86). 
This, in addition to previous findings (50, 57), suggests that environment and non-
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agricultural food sources (e.g. game animals) may play a significant role in C. coli human 
infections (86). Nevertheless, due to a bias in sampling, little is known about the host, 
genetic makeup, and potential virulence factors of C. coli clade 3.  
2.3 C. jejuni and C. coli glycobiology: from gene to glycan 
Glycans and glycoconjugates are the predominant bacterial cell surface structures. As a 
result of their location at the host-microbe interface, glycosylated structures are involved in 
shaping bacterial ecology by dictating interactions with microbes, host (92), bacteriophages 
(93), and the environment in general (94, 95). Although glycan assembly is not template 
driven, identification and classification of carbohydrate biosynthesis genes offers insights 
into structures potentially expressed by bacteria. 
2.3.1 Identification and annotation of carbohydrate-active enzymes 
Although glycan structures do not necessarily correlate with the genetic composition of a 
glycan biosynthesis locus (7, 96-98), gene content diversity is at the base of glycans 
structural heterogeneity. Therefore, identification of genes associated to carbohydrate 
synthesis and glycan modification can theoretically hint at the presence of sugar residues of 
interest.  
There are two general approaches for gene prediction—ab initio and homology-based 
prediction. Ab initio is an intrinsic method that searches for statistical patterns and DNA 
motifs within genes and their boundaries. Open reading frames (ORF) are sequences flanked 
by a translation initiation and termination site. ORF identification and inspection is the most 
basic ab initio method. Since not all ORFs are coding regions, Markov model-based 
algorithms are used to infer gene description statistically. Conversely, homology-based 
prediction, is based on the identification of sequences that evolved from a common ancestral 
sequence. This method assumes a higher level of conservation in coding sequences in 
comparison to non-coding regions (99). Similarly, functional annotation by sequence 
homology relies on the premise that during speciation the functionality of corresponding 
proteins is kept even between species. As a result, a putative function can be assigned to an 
uncharacterized protein if the activity of a protein with significant sequence similarity is 
known. Alignment of the query sequence against every sequence in the database is the first 
step in searching for homology candidates. The heuristic Basic Local Alignment Tool 
(BLAST) is the most commonly used tool for querying large sequence databases, which can 
generate either gapped alignments or position-specific iterated (PSI-BLAST) (100). The 
best BLAST hit (BBH) or the best informative BLAST hit (BIBH) are commonly assumed 
to be phylogenetically related to the query. However, when comparing distantly related 
species BBH/BIBH genes might not necessarily be homologous, resulting in misannotation 
(101). Thus, by predefining a cut-off, coding sequences groups aggregating BBHs sharing 
high homology and potentially function can be formed. These groups are usually called 
group of orthologues. Orthology is a subclassification of homology, and it generally refers 
to genes separated due to speciation (102). Group of orthologues are built using e.g. Markov 
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Cluster Algorithm (MCL) (103) analysis implemented through different tools such as 
OrthAgogue (104) and Roary (105).  
Although homologues are frequently assumed to encode proteins with similar catalytic 
properties, functional assignment based solely on homology may be unreliable. Divergent 
evolution can result in genes encoding proteins with differing specificities (7, 96, 106), or 
proteins that utilise the same type of intermediate but catalyses different reactions (107), or 
the genes may have evolved to encode proteins with both mechanism and substrate 
specificity (108). Furthermore, orthologue cluster delineation and subsequent annotation is 
further hurdled in multidomain proteins, as homology between single domains might result 
in the convergence of two protein families. Therefore, to improve annotation protein 
signature recognition methods, including profile-based, Hidden Markov Model (HMM), 
and positional specific score matrix can be implemented through e.g. InterProScan (109). 
2.3.1.1 Classification of carbohydrate related genes  
Oligo and polysaccharides are the most diverse structures in nature, with a calculated 
diversity of over 1012 for hexasaccharides alone (110). The Carbohydrate-Active enZymes 
(CAZymes) are the enzymes involved in the biosynthesis and breakdown of glycans. 
Currently, the CAZy database (CAZyDB) is the most comprehensive catalogue of 
CAZYmes with almost 400 000 unique protein sequences (http://www.cazy.org/) (12) 
classified into five functional classes; glycoside hydrolases (GHS), glycosyltransferases 
(GTs), polysaccharide lyases (PLs), carbohydrate esterases (CEs), and auxiliary activity 
enzymes (AA) (12). The GTs functional class encompasses enzymes catalysing glycosidic 
bond formation using activated sugars as donors and sugars, lipids, protein, nucleic acids, 
antibiotics, or other small molecules as acceptors. Despite the considerable variety of 
donors, staggering number of acceptors, and the cosmic diversity of products, GTs most 
likely underwent divergent evolution from few common ancestors, as reflected by the two 
types of structural folds displayed by nucleotide sugar-dependent GTs: GT-A and GT-B 
(111-113). As a result, functional annotation of GTs is a highly challenging task. Currently, 
GTs are classified into 103 families based on amino acid sequence similarity (12, 111, 114). 
This type of classification permits systematic and logical grouping of GTs into families, 
without requiring demanding functional studies, and provides insights into the families’ 
divergent evolution. Since amino acid sequence similarity is strongly correlated with protein 
folding, this classification allows grouping enzymes with similar three dimensional 
structures and molecular mechanisms. However, this classification has been shown to 
poorly correlate with enzymes specificities, as polyspecificity within a family is common 
(12, 114). Moreover, several studies have shown that substitution of a single or very few 
amino acids can modify the activity of a particular GT (7, 10). Consequently, functional 
predictions and annotations beyond family classification should be discouraged if the 
biochemical properties of the GT have not been established (98) and/or if the enzyme in 
question is not highly similar to the members of family extensively characterized as 
monospecific. To identify, classify, and annotate GTs, blasting the genome against the 
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annotated full-length CAZyDB is a common practice. However, this method requires 
manual curation of the data, and CAZy family assignment is only transferred to the most 
significant hit (115). Thus, automatic annotation methods based on HMM (115, 116) or on 
peptide pattern recognition (PPR) (117) have been developed. Yet, differences in the 
sensitivity and precision of the various methods have been observed (115, 117). In C. jejuni 
and C. coli, 15 GT families are represented among the 138 strains listed in the CAZy 
database as of April 2017. However, biochemical characterization has only been carried out 
for 12 different C. jejuni glycosyltransferases (7, 10, 96, 98, 106, 118-125). 
2.3.2 C. jejuni and C. coli carbohydrate gene clusters 
Glycans have a fundamental role in the biology and pathogenesis of C. jejuni and C. coli (4, 
5), and a significant proportion of the genome (~10%) is estimated to encode GTs and other 
enzymes involved in the synthesis and modification of sugar nucleotides and glycosylated 
structures (6). In Campylobacter genomes, these carbohydrate-related genes are mainly 
clustered in four distinct loci;  
(i) O- linked protein glycosylation pathway 
Protein O-glycosylation, a widespread pathway in bacteria, is the glycosylation of serine or 
threonine residues at the hydroxyl group commonly carried out sequentially on the surface 
exposed residues by GTs. In C. jejuni and C. coli O-glycosylation of flagella proteins FlaA 
and FlaB heavily contributes to the molecular mass of flagellin (~10%) and is essential for 
flagella assembly (126, 127). Nevertheless, the nature of flagellar glycans is strain specific 
and determined by the genetic content of the hypervariable O-glycosylation locus, which is 
located contiguous to the flagellin structural genes (6). For example, C. jejuni 81-176 has 
the smallest O-glycosylation locus reported so far with only 21 genes, some of which encode 
enzymes that synthesize 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-α-L-manno-
nunolusonic acid (pseudaminic acid, Pse5Ac7Ac) and related derivatives (127-129). C. 
jejuni 81-176 FlaA and FlaB are predominately glycosylated with Pse5Ac7Ac and 5-
acetamido-7-acetamidino-3,5,7,9-tetradeoxy-L-glycero-α-L-manno-nunolusonic acid 
(Pse5Ac7Am), and minor amounts of N-acetylglutamine (Pse5Ac7AcO-GlcAc) and O-
acetyl (Pse5Ac7AcOAc) (127, 128, 130, 131). In contrast, C. jejuni NCTC 11168 O-
glycosylation locus encompasses almost 50 genes, including a gene cluster for 5,7-
diacetamido-D- glycero-β-D-galacto-nunolusonic acid (legionaminic acid, Leg5Ac7Ac) 
synthesis and related derivatives (6). Consistently, C. jejuni NCTC 11168 flagellin proteins 
are glycosylated with Pse5Ac7Ac, Leg5Ac7Ac, and derivatives, with highly heterogeneous 
glycosylation patterns (Fig. 3) (132-135). Similarly, C. coli VC167 glycosylates its flagellin 
with Pse5Ac7Ac, Pse5Am7AcO-deoxypentose, Pse5Ac7AcO-deoxypentose, acetamidino 
(Leg5Am7Ac), and N-methylacetimidoyl Leg5AmNMe7Ac of Leg (136, 137). Hence, O-
glycosylation is genetically and phenotypically highly heterogeneous. This diversity has 





Figure 3. Structures of sialic acid and sialic acid-like sugars. Modified from (138) 
(ii) N-linked protein glycosylation systems 
Protein N-linked glycosylation is the addition of a glycan to a nitrogen atom of an asparagine 
residue. In C. jejuni and C. coli, the heptasaccharide N-glycan is a remarkably conserved 
GalNAc-α1,4-GalNAc-α1,4-[Glcβ1,3-]GalNAc-α1,4-GalNAc-α1,4-GalNAc-α1,3-Bac-
β1,N-Asn, where Bac is bacillosamine, 2,4-diacetamido-2,4,6-trideoxyglucopyranose (139-
141). Similar to eukaryotes, this glycan is linked to proteins through the asparagine in the 
Asn-Xaa-Ser/Thr motif (139). However, the en bloc N-glycosylation occurs on the surface-
exposed parts of a folded protein instead of on the unfolded protein. All the highly conserved 
enzymes required for the synthesis and transfer of the N-glycan are found within the 17 kb 
protein glycosylation locus (pgl) located adjacent to the LOS biosynthesis locus (6, 141-
143). The N-glycosylation pathway has been elucidated (144) and several of the proteins 
involved in the pathway have been fully characterized (121-124). Impairment of the N-
linked glycosylation glycosylation pathway leads to pleiotropic phenotypes in C. jejuni, 
resulting in a general decrease in bacterial fitness (145-147). 
 
(iii) Capsule  
In the early years of molecular research, C. jejuni and C. coli were thought to synthesize 
low and high molecular weight glycolipids inferred to be lipopolysaccharides (LPS). These 
structures were assumed to be the heat stable antigens that differentiated strains in the 
Penner serotyping schema, despite evidence otherwise (148). This paradigm was generally 
undisputed until the publication of the first C. jejuni genome and the identification of genes 
putatively involved in capsule (CPS) transport and assembly (kps genes) (6). Mutational 
studies of these genes demonstrated that indeed the high molecular weight glycolipid was a 
CPS (149). Additionally, Penner serotype was shown to rely on CPS structural variability 
for strain classification. Bacterial CPS is a polysaccharide chain made of variable length 
containing repeating units of one or more sugar residues, and which is loosely linked to the 
cell surface by a lipid anchor. Based on the biosynthesis mechanism, assembly, genetic 
regulation, and sequence similarity, CPS can be broadly divided into four groups (I-IV). In 
CPS group II and III gene loci, the highly conserved transport and assembly (kps genes) 
genes flank a hypervariable biosynthetic region. In general the gene order is 
kpsFEDUCS…TM for group II and kpsDMTE...CS for group III cluster. C. jejuni and C. 
coli have a II/III hybrid capsule type as the gene content and order is kpsMTEDF….CS. 
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Although genes outside the CPS locus may contribute to CPS structural variability, the 
genetic diversity within the hypervarible CPS region forms the basis of CPS heterogeneity 
(150, 151). Comparative genomics have identified 12 CPS gene content classes in C. jejuni 
(A-L) and eight in C. coli (A-H) (17, 150). 
(iv) Lipooligosaccharides  
LPS are the most abundant glycoconjugates found in Gram-negative bacteria outer leaflet 
of the outer membrane. These phosphorylated endotoxin glycolipids help to modulate host 
immune response, maintain structural integrity, and cope with environmental stresses (152, 
153). LPS is typically composed of a hydrophobic glucosamine-based lipid A anchor 
substituted with a relatively conserved core polysaccharide, and a highly variable repeating 
O-polysaccharide chain (154). A rough version of LPS devoid of the O-polysaccharide 
chain known as lipooligosaccharides (LOS) is found in C. jejuni and C. coli, as well as in 
some mucosal pathogens such as Neisseria and Haemophilus (155). In humans, free LPS 
and LOS is recognized and bound by the LPS-binding protein (LBP), which delivers the 
glycolipid to cluster of differentiation 14 (CD14). Then, CD14 presents the LPS/LOS to 
Toll-like receptor 4-myeloid differentiation factor 2 (TLR4-MD2). An intracellular 
signalling cascade is initiated upon binding of LPS/LOS to TLR4-MD2, triggering the 
innate immune response (156-158). Although only the lipid moiety of LPS/LOS is required 
for initiating the innate immune response, structural differences in the glycan fraction have 
been shown to have a modulatory effect (159-164). The genetics and structure of C. jejuni 
and C. coli LOS are extensively presented in the following chapters. 
2.4 Genetic basis of C. jejuni and C. coli LOS  
With the publication of the first C. jejuni genome (6) and the advent of whole genome 
sequencing (WGS), genotypic-phenotypic studies have been conducted to understand LOS 
structural heterogeneity and to link genetic backgrounds with disease outcomes (7, 46, 97, 
165-167). In C. jejuni and C. coli¸ LOS biosynthesis genes are clustered within the LOS 
biosynthesis locus (168, 169). The LOS locus is a hypervariable genetic region in 
Campylobacter spp. (170-173) flanked by the conserved LOS biosynthesis genes waaC and 
waaF (7). Various studies have explored the remarkable diversity and organization of gene 
complement of this locus in C. jejuni, which arises from extensive recombination and 
horizontal gene transfer (7, 17, 174-176). Comparative analysis of C. jejuni LOS loci has 
identified 40 LOS orthologues arranged in 22 gene content classes named A-W (excluding 
N) (7, 17, 174, 175). These gene content classes, known as LOS locus classes, have a mosaic 
nature as they have arisen by the insertion and/or deletion of genes or gene cassettes (7, 
175).  Similar to other virulence genes (177), a strong link between C. jejuni LOS locus 
classes and CC/STs has been observed (167, 178-181). Thus, LOS class distribution is 
associated with C. jejuni population structure (i.e. same lineages harbours same LOS 
classes).  
In contrast, the genetic makeup of the C. coli LOS biosynthesis locus was largely unknown 
until recently (17). The C. coli LOS locus was found to be more genetically diverse, as 51 
distinct orthologues were identified. Nevertheless, these orthologues were arranged in eight 
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LOS locus classes named I to VIII (17). As in C. jejuni, C. coli LOS classes appear to be 
non-randomly distributed in nature, as a strong association between LOS locus class and 
host was observed (17). Additionally, introgression of C. coli with C. jejuni was identified 
as an important genetic mechanisms for generating LOS diversity, and potentially 
influencing virulence (17).  
2.4.1 Genetic mechanisms generating C. jejuni and C. coli LOS variability 
In addition to gene content diversity, C. jejuni utilizes at least four other mechanisms to 
generate LOS structural heterogeneity (7, 96, 169, 175). Mechanisms and their respective 
examples are shown below to illustrate how minor genetic differences can have large 
repercussions on LOS structures.   
(i) Phase variation due to homopolymeric tracts  
Phase variation of surface antigenic structures is an important adaptive strategy in which 
reversible hypermutation or hypervariable methylation generates population diversity, 
which enhances bacterial survival (182, 183). Simple sequence repeat (SSR) tracts are a 
phase variation mechanism involving iterating units of one to several nucleotides. 
Mononucleotide tandems, known as homopolymeric tracts (HTs), are the simplest SSR 
commonly located within the reading frame or in the promoter region of a gene. HTs are 
highly prone to insertions or deletions during processes requiring DNA synthesis due to a 
slipped-strand mispairing mechanism. Consequently, the length of HTs is altered, producing 
reversible translational frameshift mutations in the coding sequence of a gene (182-184). 
Therefore, within a clonal population a mixture of translationally in- and out-of frame gene 
variants may be present (7). HTs between 5-13 nucleotides are commonly found in C. jejuni 
carbohydrate biosynthesis genes (6). While poly(A) and poly(T) HTs are overrepresented 
in the coding genes of several prokaryotes, poly(C) and poly(G) are the most common HTs 
in  C. jejuni (6, 185), while a sole instance of phase variable poly(A) HT within the LOS 
loci has been reported (186). LOS structural heterogeneity due to phase variation linked to 
HTs was first demonstrated in C. jejuni NCTC 11168 (169). An intragenic poly(G) HT of 
either eight or nine bases was identified in the gene wlaN. The 8-poly(G) variant encoded a 
function β-1,3-galactosyltransferase, while the 9-poly(G) expressed an inactive truncated 
version. Since WlaN transfers the terminal β-1,3-Gal in the GM1a LOS mimic, inactivation 
of this protein results in the expression of a GM2-like LOS. C. coli has been suggested to 
have HTs-linked phase variability potentially similar to C. jejuni (17). However, LOS 
structural heterogeneity due to HTs has not been examined in C. coli. In fact, the impact of 
HTs on the expression of surface structures in C. coli is limited to a single study in which a 
phase variable poly(T) HT in the flhA gene was responsible for immotile cells (187). 
(ii) Deletion/insertion of a single base without phase variation  
C. jejuni OH4384 and OH4382 carry identical 11.5 kb LOS locus class A, with the 
exception of a single base deletion at position 71 of orf5. This deletion causes a frameshift 
mutation, effectively inactivating the 1,4-N-acetylgalactosaminyltransferase encoded by 
orf5 (7, 96). As a result, C. jejuni OH4382 expresses a GD3-like LOS instead of the GT1a 
mimic synthesized by C. jejuni OH4384.  
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(iii) Loss of enzymatic activity by a single amino acid mutation 
The LOS locus class C orf5/10 of C. jejuni NCTC 11168 encodes a β-1,4-N-
acetylgalactosaminyltransferase/CMP-NeuAc synthase fusion which is essential for the 
synthesis of GM2 and GM1a mimics (7, 188). C. jejuni ATCC 43430 (LOS locus class C) 
has a single amino acid substitution (C92Y) in this gene, which abolishes the β-1,4-N-
acetylgalactosaminyltransferase activity. Consequently, C. jejuni ATCC 43430 only 
expresses a GM3-like LOS structure (7).  
(iv) Multiple mutations leading to differences in acceptor specificity  
Variants of the β-1,4-N-acetylgalactosaminyltransferase CgtA found in LOS locus classes 
A, B, and C share a 34% overall amino acid sequence identity (7). As a consequence of this 
significant sequence divergence, a marked difference in acceptor preference has been 
observed between the variants (7, 96). For example, the CgtA from C. jejuni ATCC 43438 
(LOS class A) is only active on non-sialylated acceptors. Conversely, OH4384 (LOS class 
A) is only active on monosialylated acceptors, and ATCC 43456 (LOS class B), and NCTC 
11168 (LOS class C) are active on mono- and disialylated acceptors (7, 96).  
2.5 Campylobacter jejuni and C. coli lipooligosaccharides composition and 
structure 
Research efforts have been directed at elucidating the chemical composition and structure 
of C. jejuni LOS, as several ganglioside mimics have been found in this species. Thus, 
information concerning LOS chemical structure and composition is largely limited to C. 
jejuni. This is despite the fact that C. coli has been isolated from GBS patients, and its role 
in post-infectious diseases is debated (14-16). Hence, in the following sections the 
characteristics C. jejuni LOS will be presented in detail, while C. coli data will be limited 
to the few isolates for which the LOS chemical composition is known (18, 19) and the single 
chemical structure that has been resolved (189).  
2.5.1 Lipid A  
Lipid A is the most structurally conserved moiety in both LPS and LOS, and it is essential 
for both viability and maintaining the membrane barrier (154, 155). Structural variations are 
limited to disaccharide backbone composition (D-glucosamine (GlcN) and/or 2,3-diamino-
2,3-dideoxy-D-glucose (GlcN3N)), degree of phosphorylation and phosphate substituents, 
and the length, number, and linkage of the fatty acid acyl chains (92, 143, 154, 155, 190-
192).  
Early structural studies in C. jejuni LOS revealed a heterogeneous lipid A backbone 
composed of three β(1→6)-linked hexosamine disaccharides (193), considerably distinct 
from C. fetus lipid A (194). Although differences in the relative proportion of the various 
disaccharide species have been observed between and within C. jejuni strains (143), 
GlcN3N-GlcN is generally the most abundant species followed by GlcN3N-GlcN3N and 
GlcN-GlcN (143, 164, 193, 195). Despite saccharide compositional differences, all three 
hexosamine disaccharide backbones are phosphorylated and acylated in a similar fashion, 
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giving rise to a biphosphorylated hexacylated lipid A. Disaccharides are phosphorylated at 
the hydroxyl group at C-4’ of the non-reducing hexosamine and at the glycosidic hydroxyl 
group at C-1 of the reducing hexosamine (143, 164, 193). Additionally, phosphate groups 
can be further modified with a phosphoethanolamine (PEtn) residue by the action of the 
promiscuous pEtN transferase encoded by cj0256 (eptC) (196), yielding 
pyrophosphoethanolamine (PPEtn) (143, 164, 193). This modification contributes to an 
increase in resistance to polymixin B and avian and human cationic antimicrobial peptides 
(CAMPs), and modulates the innate immune response (164, 197). 
Simultaneously, the dissacharide backbone is asymmetrically substituted with six fatty acid 
chains. At positions C-2 and C-3 the disaccharide backbone is substituted with (R)-3-
hydroxytetradecanoic acid [14:0(3-OH)], while (R)-3-(hexadecanoyloxy)tetradecanoic acid 
[3-(16:0-O)-14:0] or (R)-3-(tetradecanoyloxy)tetradecanoic acid [3-(14:0-O)-14:0] 
substitute at C-2’, and 3-(16:0-O)-14:0 at C-3’ (193, 195). Hence, fatty acid distribution in 
C. jejuni lipid A is in general isostructural to E. coli lipid A, but with a partial replacement 
of tetradecanoic acid with hexadecanoic acid (154, 198). Actually, C. jejuni lipid A 
structurally (198) resembles the general enterobacterial lipid A aside from the existence of 
GlcN3N in the backbone. The presence of GlcN3N in the disaccharide backbone results in 
an increased proportion of amide linked acyl chains. Initially, this structural difference was 
regarded as inconsequential to C. jejuni LOS antigenic activity (20, 193, 199, 200). 
However, upon the characterization of the enzymes essential for the synthesis of GlcN3N 
substituted lipid A, GnnA and GnnB, in Acidithiobacillus ferroxidans (201) and the 
identification of these protein homologues in C. jejuni 11168 (Cj0504c and Cj0505c, 40% 
and 55% amino acid similarity, respectively), the true impact of GlcN3N on C. jejuni LOS 
antigenicity was recognised (202). Deletion of either C. jejuni 11168 gnnA or gnnB 
(Cj0504c and Cj0505c, 40% and 55% amino acid similarity to A. ferroxidans, respectively) 
resulted in the addition of an ester-linked acyl chain instead of an amide-linked acyl chain 
(202). Substitution of ester-linked with amide-linked acyl chains causes a decrease in the 
antigenic activity of C. jejuni LOS on human TLR4-MD2 and tumour necrosis factor alpha 
(TNFα) expression (164, 202). Thus, variability in the proportion of amide-linked acyl 
chains has direct impact on the modulation of the innate immune response (164, 202). In 
contrast to C. jejuni, C. coli lipid A composition has only being superficially analysed by 
Naess and Hostad (18), as C. coli LOS chemical studies have been solely focused on 
determining the LOS core composition (18-22). Thus, the nature of the disaccharide 
backbone, and the degree of acylation and phosphorylation in C. coli lipid A has been long 
assumed to be identical to C. jejuni, even though lipid A structural differences have been 
observed within the Campylobacter genus (194).  
2.5.2 LOS inner core 
Based on the composition of the polysaccharide core, this moiety can be subdivided into 
inner core and outer core (154). The inner core is the region proximal to the lipid A, and it 
is distinguished from the outer core by the presence of L-glycero-D-manno-heptopyranose 
(L,D-Hep), D-glycero-D-manno-heptopyranose (D,D-Hep), and most importantly, 3-
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deoxy-D-manno-octulosonic acid (KDO). Regardless of the bacterial species, all LPS and 
LOS studied thus far contain at least one KDO residue which links the lipid A hexosamine 
disaccharide backbone at position C-6 with the inner core (154, 155). Similar to lipid A, the 
backbone structure of the LPS inner core is largely conserved within closely related species 
such as within the Enterobacteriaceae family. In E. coli, five core types (R1-R4 and K12) 
have been described for over 100 different serotypes (203). The tetrasaccharide Glc-α(1,3)-
L,D-Hep-α(1,3)-L,D-Hep-α(1,5)-KDO is the typical enterobacterial inner core.  
Nevertheless, heterogeneity in the inner core may arise from nonstoichiometric substitutions 
with residues such as rhamnose (Rha), galactose (Gal), GlcN, N-acetylglucosamine 
(GlcNAc), KDO, phosphate and phosphorylethanolamine (PEtN). In contrast to LPS, LOS 
inner core is less conserved among different species (155). All C. jejuni studied to date have 
a LOS basic inner core composed of L,D-Hep-α(1,3)-L,D-Hep-α(1,5)-KDO, where the L,D-
Hep adjacent to KDO is substituted with a  D-glucose in β(1,4) linkage (8, 33, 34, 143, 195, 
204-209). Although the typical Enterobacteriaceae tetrasaccharide inner core has been 
found in some C. jejuni strains, the vast majority of the strains have a Gal residue β(1,3) 
linked to the second L,D-Hep (8, 33, 34, 143, 204-209)  instead of a Glc residue (8, 204). 
Additionally, the inner core region can be further derivatized by the action of EptC. As in 
the lipid A, EptC transfers a pEtN residue to the innermost Hep (152, 197). The influence 
that this inner core modification has on virulence and host-pathogen interaction is unknown 
due to the pleiotropy of EptC (197). The single available C. coli LOS inner core resembles 
C. jejuni basic inner core, with the exception of a further substitution of β(1,4) Glc with a 
β(1,3) Hep and the absence of phosphate substituents in the inner core (21).  
2.5.3 LOS outer core 
The outer core is the most variable region in C. jejuni LOS, and with greater interstrain 
variability than that observed in E. coli (210). Typically, LPS or LOS outer core regions are 
composed of D-glucose (Glc), D-galactose (Gal), GlcNAc, and N-acetyl-D-galactosamine 
(GalNAc) (154, 155). However, chemical and structural studies of the C. jejuni outer core 
revealed the presence of two uncommon features—N-acetylneuraminic acid (Neu5Ac, sialic 
acid) (8, 33, 34, 143, 204, 206, 207) and 3-amino-3,6-dideoxy-D-glucose (Qui3N), 
commonly found as a 3-acetamido-3,6-dideoxy-D-glucose (Qui3NAc) residue (8, 143, 205, 
208, 209). Based on the available chemical studies on C. jejuni LOS, the presence of 
Neu5Ac and Qui3NAc appear to be mutually exclusive (8, 33, 34, 143, 204-209). Neu5Ac 
is the most abundant nonulosonic acid found widespread on eukaryotic surface glycans, but 
relatively uncommon in prokaryotic organisms (211, 212). Conversely, Qui3NAc is an 
unusual dideoxyamino sugar which thus far has been exclusively reported in a limited 
number of bacterial surface structures. Qui3N has been found in all C. coli strains analysed 
to date, suggesting that this residue is characteristic of C. coli LOS (18-22). In contrast to 
C. jejuni, Qui3N is found in C. coli in an N-acylated form (Qui3NAcyl), with either (R)-3-
hydroxybutanoyl or 3-hydroxy-2,3-dimethyl-5-oxoprolyl as N-acyl groups (21). 
Interestingly, Qui3NAcyl residues were found to cap C. coli LOS (21). Thus, it is tempting 
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to speculate that Qui3NAcyl may play an important role in many biological interactions due 
to its ubiquity and position in C. coli LOS structure.  
2.6 Biosynthesis of Sialyl-glycoconjugates 
Nonulosonic acids are a highly diverse structural class of nine-carbon α-keto acids (213). 
Nevertheless, the presence of nonulosonic acids in glycoconjugate has been shown to be 
key in the pathogenesis of various bacterial species (214). There are two subclasses of 
nonulosonic acids: the 5,7-diamino-3,5,7,9-tetradeoxy-non-2-ulosonic acids, which 
includes legionaminic and pseudaminic acids; and the 5-amino-2-keto-3-deoxy-5-
acetamido-D-glycero-D-galacto-nonulosonic, known as sialic acid (acetylneuraminic acid, 
Neu5Ac). First discovered in 1936 in the bovine submaxillary mucin, hence the Greek name 
‘sialon’, sialic acid is the most widely distributed nonulosonic subclass (215, 216). This 
subclass is a family of over 50 naturally occurring sugars derived from Neu5Ac and 2-keto-
3 deoxy-D-D-glycero-D-galcto-2-nonulosonic acid (KDN), the former being the most 
common sialic acid in nature (212, 217). Sialic acids are often found capping the outer ends 
of glycans on all vertebrate cell surfaces and in the cell surface of some bacteria (218). 
Frequently, these bacteria are pathogenic and sialylation of surface structures allows them 
to circumvent the immune system (214, 219, 220). Bacteria utilize four different 
mechanisms for cell surface sialylation: de novo synthesis, trans-sialidase, and donor or 
precursor scavenging (219, 221).  
For LOS sialylation, C. jejuni requires genes encoding enzymes involved in de novo 
synthesis of activated Neu5Ac and transfer (see below). Based on their genetic content, only 
C. jejuni strains carrying an A, B, C, M, R, or V LOS locus class can potentially exhibit a 
sialylated LOS structure (7, 17, 174, 175). In fact, the LOS from representative strains from 
all these classes, except V, have been shown to be sialylated (7, 9, 10, 96, 222). LOS locus 
classes, A, B, and, C have been of particular interest due to their association with ganglioside 
biosynthesis and GBS (9, 46, 165, 223, 224). In contrast, none of the C. coli LOS classes 
reported to date carry all of the genes associated with the expression of a sialylated LOS 
structure (17).  Therefore, the following sections will be limited to the synthesis and transfer 
of Neu5Ac in C. jejuni.  
2.6.1 Sialic acid biosynthesis genes 
Sialic acids are peculiar sugars synthesized through the condensation of a neutral six carbon 
molecule with a three carbon pyruvate, and activated with a high energy nucleotide (212). 
Neu5Ac biosynthesis genes (neu) were first identified in region 2 of E. coli K1 CPS locus 
(225). In bacteria, de novo Neu5Ac biosynthesis begins with the epimerization of UDP-
GlcNac to ManNAc (N-acetylmannosamine) by a UDP-N- GlcNac 2-epimerase (NeuC) 
(226). Then, ManNAc is condensed with phosphoenolpyruvate (PEP) to form Neu5Ac by 
an N-acetylneuraminic acid synthetase (NeuB) (227). Finally, free Neu5Ac is activated with 
cytidine triphosphate to form cytidine 5’-monophosphate (CMP)-Neu5Ac by the action of 
a CMP-N-acetylneuraminic acid synthetase (NeuA) (228). Similar biosynthetic steps have 
been observed in the synthesis of other nonulosonic acid sugars such as legionaminic and 
pseudaminic acid, and KDN, and reactions are catalysed by homologous enzymes (131, 
138, 211). In the nonulosonic acid biosynthesis pathway the enzyme involved in the 
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condensation of a 6-carbon molecule with PEP (NeuB in Neu5Ac synthesis) is the most 
conserved (203). Additionally, partial homology to nonulosonic biosynthesis enzymes has 
been observed in the KDO biosynthesis pathway. In fact, the structure, biosynthesis (by 
condensation of D-arabinose with PEP), and activation (CMP-nucleotide) of this bacterial 
eight carbon α-keto acid is very similar to nonulosonic acids (212, 221, 229).  
In C. jejuni three NeuB homologues have been identified: Cj1141, Cj1327, and Cj1317 (6, 
230). Although all NeuB homologues were shown to restore E. coli EV24 sensitivity to K1 
bacteriophage, only Cj1141 was shown to synthesize Neu5Ac de novo at significant levels 
(230). Additionally, mutational studies revealed the loss of a GM1-like LOS structure upon 
deletion of cj1141, while cj1327 and cj1317 deletions had no effect on LOS structure (230). 
Consequently, the protein encoded by cj1141 was confirmed to be a Neu5Ac synthetase 
(neuB) involved in sialylated LOS biosynthesis (230). Later studies identified Cj1327 and 
Cj1317 as legionaminic (NeuB2, PtmC, LegI) and pseudaminic acid synthetases (NeuB3, 
PseI), respectively (131, 138). 
Downstream from neuB, a putative UDP-N- GlcNac 2-epimerase (cj1142) and a putative 
CMP-Neu5Ac synthase (cj1143) were identified (6, 230). Similar to neuB, deletion of 
cj1142 resulted in an asialylated LOS structure (231). However, deletion of cj1143 did not 
result in the loss of Neu5Ac from the LOS core, possibly due to the activity of NeuA 
homologues from the legionaminic and pseudaminic acid biosynthesis pathway (231).  
2.6.2 Sialyltransferases 
Sialyltransferases are key enzymes in the synthesis of sialylated glycoconjugates. 
Sialyltransferases are inverting GTs which catalyse the formation of an α-sialoside from, 
typically, the activated donor CMP-β-Neu5Ac (232-237). Characterized sialyltransferases 
have been shown to catalyse the formation of α2,3-, α2,6-, or α2,3/8-sialyl linkages, while 
polysialyltransferases synthesize α2,8-, α2,9- or alternating α2,8/α2,9-sialyl linkages (12, 
217). Terminal Gal, GalNAc, and Neu5Ac, are the most commonly recognized acceptors 
by sialyltransferases. In contrast to mammalian sialyltransferases, which are commonly 
monofunctional and have strict substrate specificity, many bacterial sialyltransferases 
exhibit sialidase and trans-sialidase activities, as well as substrate promiscuity (120, 217, 
238, 239). Following the sequence-based classification available at the CAZy server 
(www.cazy.org), sialyltransferases have been categorized into six glycosyltransferases 
families (12). Eukaryotes and virus sialyltransferases are restricted to GT-29 family, while 
prokaryotic sialyltransferases are found in the GT38 (polysialyltransferases), GT-42, GT-
52, GT-80, and GT-97 families (217, 238, 240). 
So far, three sialyltransferases have been identified in C. jejuni: CstI, CstII, and CstIII. All 
three enzymes belong to the GT42 family, which is currently comprised of enzymes with 
sialyltransferase, sialidase, and trans-sialidase activities. 
The CstII from C. jejuni was the first chemically and structurally characterized GT42 (96, 
119). In solution, CstII is a tetramer in which each monomer is organized into two closely 
associated domains: the main central domain is a single mixed α/β Rossmann fold 
containing the nucleotide-binding domain, while the secondary domain is a long coil with 
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two helices that form a lid-like structure that folds over the active site (118, 119). Since the 
DxD motif is absent, CstII has a GT-A variant 1 type structure (119). CstII is either a mono 
or bifunctional α2,3/8-sialyltransferase with α2,8-sialidase and α2,8-trans-sialidase 
activities, and broad acceptor flexibility (120, 236, 241, 242). The bifunctional CstII variant 
is approximately 93–97% identical to the monofunctional variant (7), and a single amino 
acid substitution (N51T) has been shown to abolish α2,8-ST activity (7). The bifunctional 
CstII variant demonstrates good α2,3-sialyltransferase activity on Lac and LacNAc 
acceptors, and excellent α2,8-activity on α2,3-sialosides and α2,6-sialosides. Additionally, 
CstII can utilize CMP-Neu5Gc and CMP-KDN as donors, albeit at a lower transfer rate 
(120, 232).  
Similar to CstII, CstI is a tetramer with GT-A variant 1 type monomers. However, each 
monomer carries an additional C-terminal domain of unknown function (125). Amino acid 
residues involved in substrate binding and catalysis are conserved between CstI and CstII, 
despite their overall low sequence identity (42%) (119, 125). CstI has been shown to have 
good sialyltransferase activity on Gal and Lac type II, and a broad acceptor tolerance (236, 




3 AIMS OF THIS STUDY 
The main aim of this study was to investigate the diversity of C. coli LOS biosynthesis 
locus with particular interest in identifying genetic features associated with the synthesis 
and transfer of nonulosonic acid. An additional aim was to investigate the presence of 
nonulosonic acid in C. coli LOS. 
The specific aims were: 
1. To investigate C. coli LOS locus diversity. Studies II and III. 
2. To examine the impact of horizontal gene transfer in shaping C. coli LOS locus. 
Studies I-III. 
3. To identify and assess the distribution of the molecular machinery associated to the 
synthesis of sialylated LOS. Studies II and III. 





4 MATERIALS AND METHODS 
4.1 Bacterial isolates and DNA extraction (I, II, and IV) 
A total of 144 C. coli isolates (90 swine, 34 humans, 18 poultry, and 2 wild birds) from 
previous studies (56, 247-252) and from the Campynet (CNET) collection (hosted by 
DSMZ GmbH [https://www.dsmz.de/]) were selected based on genotype and origin to 
encompass the greatest possible diversity. Isolates were retrieved from -70 ºC frozen stocks 
and routinely cultured on Nutrient broth Nº2 (CM0067, Oxoid) with 1.5% (w/v) of agar 
supplemented with 5% (v/v) defibrinated horse blood (NA plates), unless otherwise 
specified. All strains were incubated at 37 ºC overnight under microaerobic conditions. 
DNA was isolated using the Wizard Genomic DNA Purification Kit (Promega, Germany) 
or using the PureLink Genomic DNA kit (Life technologies, USA). Species was confirmed 
using species-specific PCR (253).  
 
4.2 Whole genome sequencing and assembly (I-III) 
In study I, C. coli 76339 genome was sequenced using 454 Titanium (LGC Genomics 
GmbH, Germany) with a coverage of > 30×. The genome was assembled into a scaffold 
using a combination of pair-end and 8 kb mate-pair libraries with MIRA 3.2. (254), SSAKE 
(255), and Staden (256). Scaffolds were verified by PCR and Sanger sequencing.  
In study II, either HiSeq or MiSeq were used to sequence the draft genome of a total of 35 
isolates. HiSeq library preparation, enrichment, sequencing, and sequence analyses were 
performed by the Institute for Molecular Medicine Finland (FIMM Technology Center, 
Finland). MiSeq sequencing was performed by the Institute of Life Science, Swansea 
University (Swansea, United Kingdom). Reads were filtered and assembled with SPAdes 
Assembler v. 3.3.0 (257).  
In study III, raw sequencing data of a selected group of C. coli strains was retrieved from 
ENA with getSeqENA (https://github.com/B-UMMI/getSeqENA). Using the INNUca 
pipeline (https://github.com/INNUENDOCON/INNUca), paired-end raw reads were 
assembled if the raw data fulfilled the expected minimum 15x coverage. Quality analysed 
reads with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), were 
cleaned with Trimmomatic (258). Then, de novo draft genome assembly was performed 
with SPAdes 3.11 (257) and the assembly depth of coverage was checked (min 30x). 
Following draft genome improvement with Pilon (259), species was confirmed and MLST 





4.3 Genome annotation (I-III) 
All genomes in study I and II were primarily annotated with Rapid Annotation Using 
Subsystems Technology (RAST) (260). For C. coli 76339 genome (study I), Artemis (261) 
was used to manually curate and re-annotated genes of interest. Gene homology was 
identified using NCBI’s BLAST suite of programs, using UniProtKB/Swiss-Prot (262) as a 
reference database. Protein conserved functional domains were identified with InterProScan 
(263). The whole-genome sequences of all C. coli, with the exception of 76339, are publicly 
available on the RAST server (http://rast.nmpdr.org) with a guest account (login and 
password ‘guest’) under accession numbers 195.91, 195.96 to 195.119, 195.124 to 195.126, 
195.128 to 195.130, 195.133, 195.134, and 6666666.94320. The genome of C. coli 76339 
was deposited in EMBL with the accession number HG326877.   
In study III, draft genomes passing INNUca QA/QC were annotated with Prokka (264), 
while pangenome analysis was carried out with Roary (105) (default parameters). 
4.3.1 LOS locus annotation (I-III) 
Glycosyltransferases were predicted based on the annotation available in the CAZy database 
(12). Assemblies were manually inspected with Artemis (261), and LOS locus classes were 
aligned and compared with ACT (265). 
4.3.2 Improvement of C. coli 76339 LOS annotation (I) 
To improve the gene prediction and to identify the transcription units for the genes included 
in the C. coli 76339 LOS biosynthesis locus a transcriptome analysis was performed. Total 
RNA was extracted from a culture grown for 16 h in nutrient broth 2 (Oxoid) (100 rpm, 
microaerobic atmosphere, and 37°C) using GeneJet RNA purification kit (Thermo 
Scientific). Dnase I treatment, rRNA depletion, and RNA sequencing were carried out by 
BaseClear (Netherlands). Single-end sequence reads were produced using the Illumina 
HiSeq2500 system. Illumina Casava pipeline version 1.8.3 was used to generate FASTQ 
sequence files. Adapters were clipped yielding reads of a minimum read length of 50 bp. 
The obtained FASTQ files were filtered for PhiX control signals and for reads that did not 
pass the Illumina Chastity. The final raw reads quality assessment was performed with 
FASTQC quality control tool version 0.10.0. Sequence reads were mapped against the C. 
coli 76339 genome with Rockhopper with default parameters (266).  
4.4 Orthologue clustering and phylogenetic analysis (II) 
A database including all C. jejuni and C. coli LOS biosynthesis translated coding sequences 
was assembled following Richards et al. orthologue nomenclature (17). Groups of 
orthologues (GOs) were determined with orthAgogue and MCL (103, 104), and aligned and 
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back-translated to nucleotide sequence with MUSCLE and Translatorx Perl script (267-269) 
as described in study II (270). Maximum likelihood phylogenetic reconstruction of each 
GO, in which C. jejuni and C. coli orthologues were admixed, was performed in 
MEGA6.06. To model the evolutionary rate differences among sites, the Kimura two-
parameter model and a discrete gamma distribution (4 categories) was used (271). Results 
from 100 bootstrap runs were summarized in a 95% consensus tree. 
4.5 Identification of C. coli GT-42 homologues (III) 
C. coli reference genes homologous to C. jejuni GT-42 encoding genes were collected as 
follows. First, the non-redundant (nr) NCBI protein sequences collection was searched for 
C. coli Blastp hits (> 30% of amino acid identity; > 50% query coverage) using the amino 
acid sequences of CstI (Uniprot Q9RGF1), CstII (Uniprot Q9F0M9) and CstIII (Uniprot 
Q7BP25) and blast+ V 2.7.1 (272). Non-partial sequences were used for an all-versus-all 
blastp analysis, and classified into groups with > 0.7 Blastp Score Ratio (BSR) (273). A 
back-translated nucleotide sequence alignment of all the identified C. coli GT-42 proteins 
and C. jejuni cstI, cstII, and cstIII was built with MUSCLE (default parameters) (268). This 
alignment was used to infer a Minimum Evolution phylogenetic tree using MEGA (274). 
4.6 Genome sequences mining, genes screening, and allele calling (III) 
All the Campylobacter coli and Campylobacter jejuni whole genome raw sequence reads 
entries at the time of analysis (August 2017) were retrieved from the European Nucleotide 
Archive (ENA) using the ReMatCh framework v3.2 (https://github.com/B-
UMMI/ReMatCh) (275).  
 
To perform variant calling and inferring presence or absence of selected genes, reads were 
mapped against a set of reference genes (see below) using ReMatCh. A minimum coverage 
depth of 5x was required to consider a position to be present in the alignment, and 10x to 
perform allele calling. Additionally, to consider a locus to be present; successful mapping 
of at least 70% of the target reference gene sequence and ≥ 80% identity of the consensus 
sequence at nucleotide level were required.  
 
4.6.1 Campylobacter coli clade identification 
C. coli samples were assigned to one of the three previously described major phylogenetic 
clades (66, 276) by performing population structure analysis and inferred phylogenetic 
relationships based on the atpA gene (277). C. coli RM2228 atpA sequence of (KF855277) 
was used as reference for allele calling in all C. coli strains using ReMatCh as in 4.6. 
ReMatCh atpA consensus sequence alignment was then used for sample clustering at the 
first level with hierBAPS (278). MEGA7 (274) was then used to infer a Neighbor joining 
phylogenetic tree. To classify the clusters, C. coli strains representing the different clades 
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were used as reference (66, 276), and a group of C. jejuni strains were used as outgroup. 
The resulting tree was visualized in iTOL (279). 
4.6.2 Frequency of GT-42 genes in C. coli and C. jejuni 
To assess the frequency and distribution of GT-42 genes, identified C. coli GT-42 nucleotide 
sequences (see 4.5) were used as reference for calling orthologues in all C. coli and C. jejuni 
strains using ReMatCh as described in 4.6. 
4.6.3 Classification of C. coli samples into a LOS locus class  
To classify C. coli samples into a LOS class (17), orthologues in all GT-42 positive C. coli 
samples were called with ReMatCh, as described in 4.6, using the nucleotide sequences of 
loci located between the ‘conserved putative two-domain glycosyltransferase’ (orthologue 
16 in Richards et al. (17)) and the ‘LOS biosynthesis glycosyltransferase waaV’ (orthologue 
10  in Richards et al. (17)) from previously described C. coli LOS locus classes. Results 
were reported as a percentage of genes present for a given LOS locus class. 
4.7 Pangenome analysis and gene flow investigation of LOS loci (III) 
To infer HGT between C. coli clades, presence/absence of LOS associated group of 
orthologues were mapped into the atpA tree (see 4.6.1). To assess possible gene transfer 
between C. coli and C. jejuni, the nt NCBI database was searched with blastn using 
representative sequences of C. coli LOS associated group of orthologues. HGT between 
the two species was detected if the best blast hit for C. jejuni was > 90% nucleotide 
identity over > 70% of the C. coli query length. 
4.8 Protein structure prediction 
A protein sequence alignment of all characterized GT-42 enzymes was performed with 
MUSCLE (268). The sequence alignment was coloured with Sequence Manipulation Suite: 
Color Align Conservation (http://www.bioinformatics.org/sms2/color_align_cons.html). 
Three-dimensional structures of CstIV and CstV were predicted with the Phyre2 server 
(280). Both models were generated using C. jejuni CstII (1ro7) structure as a template. 
SuSPect was used to identify structurally, evolutionary, and functionally important regions 
(281). The quality of the generated models was assessed using the QMEAN Server for 
Model Quality Estimation (282).  
4.9 LOS locus typing (II) 
Previously reported LOS classes IV and V (17) were found to be the same LOS class by 
global alignment with progressiveMauve (283). Thus, they are considered as a single class, 
henceforth named IV/V. The LOS class of C. coli strains was determined by a newly 
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developed typing scheme (270). To determine the length of the LOS biosynthesis loci the 
region between orthologue 10 (LOS biosynthesis glycosyltransferase, waaV) and 
orthologue 16 (uncharacterized glycosyltransferase) (identifications numbers according to 
(17)) was amplified as follows: 25 μl reaction mixtures containing 0.5 U Phusion high-
fidelity DNA polymerase (Thermo Scientific), 200 μM each deoxynucleoside triphosphate 
(dNTP) (Thermo Scientific), 0.4 μM each primer (ORF3F2 and waaV-R) (Table 1), 1× 
Phusion GC buffer (Thermo Scientific), 700 μM MgCl2 (Thermo Scientific), and 50 ng of 
the template, were prepared. Then, PCR reactions were subjected to the following cycling 
conditions: 1 cycle at 98 °C for 30 s followed by 30 cycles of denaturation at 98 °C for 10 
s, annealing at 62.4 °C for 30 s, extension at 72 °C for 6 min, and a final elongation step at 
72 °C for 6 min. PCR products were run in 0.5% SeaKem LE agarose in TBE buffer. 
Products were run at 60 V for 16 h. The 1-kb-plus (Thermo Scientific) and long-range 
(Thermo Scientific) molecular weight markers were used to estimate the size of the 
amplification products. To determine the putative LOS class, primers were designed based 
on specific features characterizing each LOS locus class using, when possible, multiple-
sequence alignments of homologous sequences to improve sensitivity and specificity. 
Primer pairs and their amplicon sizes for each LOS class are shown in Table 1 of Study II, 
and a graphic representation of the primer annealing positions within the LOS locus is 
shown in Suppl. Fig. 2 of Study II. Preliminary gradient PCR was performed for each primer 
pair to select the most stringent conditions to minimize artefacts. PCRs were carried out in 
a semi-high-throughput manner; thus, isolates were classified into a LOS class based on the 
results of all PCRs. Isolates with an unexpected LOS size, negative for all tested 
orthologues, or with unexpected combinations of orthologues were classified as untypable.  
4.10 LOS phenotype (II and IV) 
LOS electrophoresis patterns were visualized by silver staining. To do so, the absorbance 
of the biomass obtained from a culture grown for 16 h in nutrient broth 2 (Oxoid) (100 rpm, 
microaerobic atmosphere, and 37 °C) was adjusted to an optical density of 0.5 at  600 nm 
(OD600). Then, cells were digested with 20 mg/ml proteinase K (Thermo Scientific) at 55 
°C for 1 h, followed by boiling for 10 min. Samples were then diluted 1:5 in SDS loading 
buffer and resolved in 15% SDS-PAGE gels. Gels were silver stained for visualization by 
fixing the gels in fixation solution (27% isopropanol, 7% acetic acid v/v) 24 h at with 40 
rpm shaking. Then, gels were incubated in fixation solution with 7% periodic acid for 5 min 
and washed three times in ddH2O for 15 min at 40 rpm. Afterwards, gels were stained in 
freshly prepared silver staining solution (0.87% AgNO3, 0.52% NH4OH in 0.024 M NaOH 
w/v) for 10 min at 70 rpm, followed by three washes in ddH2O for 10 min at 40 rpm. Finally, 
gels were developed in a formaldehyde developer (0.93% formaldehyde in 1.3 mM citric 
acid, v/v). LOS sensitivity to neuraminidase was assessed by incubating crude LOS with 2 
U/ml of Clostridium perfringens neuraminidase (Sigma) overnight at 37 °C. Electrophoretic 
patterns of neuraminidase treated vs untreated were visualized as above. The presence of 
Neu5Ac in C. coli 76339 LOS was assessed by high performance anion-exchange 
chromatography with pulsed amperometric detection (HPAEC-PAD) as described in study 
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I (276). LOS chemical composition was determined by electrophoresis-assisted open 
tubular liquid chromatography–electrospray mass spectrometry (EA-OTLC-MS) analysis 
from lyophilized biomass as described in study II (270).  
4.11 Construction of C. coli isogenic mutants (IV) 
The ∆cstIV, ∆cstV, ∆cstI, ∆neuB1, ∆neuB2, and ∆neuB3 mutants were constructed as 
follows. The genes cstV (orthologue 1501), cstI (BN865_06990), and neuB1 (orthologue 9) 
in C. coli 76339, and ∆cstIV (orthologue 1501) in C. coli 65 and 73, and ∆neuB2 in C. coli 
73 were knocked out by homologous recombination with erythromycin resistance cassette 
(EryC) as described before (284), with the exception of cstI which was recombined with a 
chloramphenicol acetyltransferase cassette (CAT) (285). In brief, target genes with at least 
300 bp downstream and upstream were amplified. Then, PCR fragments were restricted and 
cloned into pUC119 vector. Resulting plasmids were used as a template for inverse PCR. 
EryC or CAT were ligated to the inverse PCR product either in the same or opposite 
orientation as the gene of interest (Suppl. Table 1, Study IV). Generated plasmids were used 
as suicide plasmids (Suppl. Fig. 1-5, Study IV). Preparation of electrocompetent cells and 
transformations were done as previously described (285). Selection of ∆cstIV, ∆cstV, 
∆neuB1, and ∆neuB2 mutants was done on nutrient blood agar (NBA) supplemented with 
10 μg ml-1 of erythromycin, while ∆cstI mutants were selected in NBA supplemented with 
12.5 μg ml-1 of chloramphenicol. Homologous recombination of all mutants was verified by 
PCR. The complete list of primers and constructs generated can be found in the 
supplementary material of publication IV.  
4.11.1 Complementation of C. coli 76339 ∆cstV-SR (IV) 
Complementation of C. coli 76339 ∆cstV-SR4 was done in cis by integration of cstV under 
the active promoter of gamma glutalmyltranspeptidase (ggt). A suicide vector was built by 
amplifying ggt and ligating it to pGEM-T plasmid (Suppl. Fig. 6, Study IV). The resulting 
plasmid was subjected to inverse PCR and ligated to cstV and CAT. Homologous 
recombination of mutants was verified by PCR, RT-PCR and by testing for GGT activity as 
described earlier (177). 
4.12 Sialyltransferase activity test in C. coli protein extracts (IV) 
To test for sialyltransferase activity, C. coli 65, 73, and 76339 were grown for 16 h in 
nutrient broth 2 (Oxoid) (100 rpm, microaerobic atmosphere, and 37 °C). Cells were 
harvested by centrifugation and (10 000 × g for 15 min at 4°C) and resuspended in 50 mM 
HEPES pH 7.5 containing a protease inhibitor cocktail (Sigma). Cells were then lysed by 
mechanical disruption and debris was removed by centrifugation (10 000 × g for 15 min at 
4°C).  
Sialyltransferase activity of protein extracts was tested on boron-dipyrromethene or 
BODIPY (BDP) labelled Lac, LacNac, and 3’Siayllactose or fluorescein (FCHASE) 
labelled α-GalNAc, β-GalNAc, GM3, α-Gal, β-GlcNAc, α-Glc, β-Glc, Hep, as donors. 
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Reactions were performed at 37 °C in 10 μl volumes containing 50 mM HEPES pH 7.5, 10 
mM MgCl2, 1 mM CMP-NeuAc, 0.5 mM labelled acceptor, and 6 μl of extract. To stop 
enzymatic reactions, an equal volume of 80% acetonitrile was added. Enzymatic activity 
was assessed by thin-layer chromatography on silica using a solvent system of ethyl 
acetate/methanol/water/acetic acid 4:2:1:0.1. 
4.13 Expression and activity of C. coli GT-42 enzymes (IV) 
4.13.1 Construction of protein expression vectors 
Gene cstIV from C. coli 73 and and cstV from C. coli 76339 were amplified and restricted. 
Both genes were ligated to pCw and pCw-MalET plamids (106) (See supplemental material 
from IV). Ligation products were then electroporated in E. coli 10β for plasmid 
amplification. After sequence confirmation, plasmids were electroporated into E. coli 
AD202 or E. coli BL21 for protein expression.  
4.13.2 Protein expression, extraction, and screening 
Cells containing the protein expression vectors were grown in 200 mL of 2YT medium 
supplemented with 150 μg/mL ampicillin and 0.2% of glucose at 25 °C with 250 rpm 
shaking. After reaching A600nm of ~0.6, protein over-expression was induced with 0.5 mM 
isopropyl-β-D-thiogalactopyranoside (IPTG) and cultures were further incubated for 16 h. 
Cells were harvested by centrifugation (10 000 × g for 15 min at 4°C). Then, cells were 
resuspended and lysed as in 4.12. Crude protein extracts were run in 12% SDS-PAGE gels 
and stained with Coomassie blue to verify protein overexpression. Protein extracts were 
screened for sialyltransferase activity as in 4.12. 
4.13.3 Cell free expression of CstIV and CstV 
The genes cstIV and cstV were synthesized with a T7 promoter and a ribosome binding site 
upstream of the coding sequence and a T7 terminator downstream from the stop codon 
(Thermo Scientific). Synthesized products were inserted into pMA-T vector backbone. 
Plasmids were subjected to PCR with pExp-F and pExp-R primers. PCR products 
were verified in gel and purified with GeneJet PCR purification kit (Thermo Scientific). 
Purified PCR products were used as a template in cell-free in vitro translation with 
PURExpress in vitro Protein Synthesis Kit (New England Biolabs Inc.). Synthesized 
proteins were screened for sialyltransferase activity as in 4.12. 
4.14 Statistical analysis (II and III) 
Host-LOS locus class associations and clade and GT-42 associations were assessed by 







5.1 Novel C. coli LOS locus classes and GT-42 homologues (I-III) 
Inspection of the first fully closed C. coli clade 3 genome (C. coli 76339) revealed a new 
LOS locus class; IX. LOS locus class IX contains four orthologues predicted to be involved 
in the synthesis and transfer of Neu5Ac: neuA, neuB, neuC, and cstV. The discovery of the 
first C. coli LOS locus class containing the essential genetic elements to potentially 
synthesize sialylated LOS structures prompted an in-depth study of C. coli LOS locus 
diversity.  
The novel PCR typing scheme developed and validated in study II failed to classify 33.33% 
of the studied isolates into one of the seven previously reported C. coli LOS locus classes 
(17). Based on the sequencing results of eight untypable isolates, three new LOS locus 
classes were described: X, XI, and XII. In light of the elucidation of these three new C. coli 
LOS locus classes, the LOS typing scheme was expanded and all previously untypable 
strains were screened. Nevertheless, approximately 15% of the isolates remained untypable 
by the expanded PCR schema (Suppl. Fig. 2 in Study II). 
 
Since no strain, aside from C. coli 76339, contained the genetic machinery to potentially 
express sialylated LOS, C. coli whole genome sequences available in public databases were 
systematically searched for the presence of GT-42 genes. 
 
5.1.1 Identification of C. coli GT-42 homologues (III) 
A group of C. coli GT-42 reference genes was collected by searching the non-redundant 
NCBI protein sequence collection using C. jejuni CstI, CstII, and CstIII (>30% amino acid 
identitiy; >50% query coverage). A total of 39 C. coli complete GT-42 coding sequences 
were identified. Sequences clustered into 7 different groups based on BSR, which varied 
between 0.8 and 0.98 (Table 1, Study III). These groups form monophyletic clades and are 
divided into two clusters: A and B (Fig. 1, Study III). Cluster A includes CstI, CstII, CstIII, 
and the newly identified CstVII, whereas cluster B comprises CstIV, CstV, and CstVI. In 
general, groups in cluster A were highly similar to C. jejuni GT-42 enzymes, while cluster 
B groups showed limited homology.  
 
5.1.2 Frequency and distribution of C. coli GT-42 homologues (III) 
To determine the frequency and distribution of GT-42 genes in the C. coli population a total 
of 2 432 C. coli genomes were mapped against all the 39 GT-42 reference sequences (See 
5.1.1). Approximately 32% out of the genomes were positive for at least one GT-42 
encoding gene (Table 2 and Suppl. Table 4, Study III). The cstVI was the most common 
GT-42 (49.35%), whereas cstIII was the rarest. Furthermore, ~5% of identified GT-42 genes 
were highly homologous to C. jejuni GT-42 enzymes. Statistical analysis revealed that C. 
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coli Clade 2 isolates are underrepresented among GT-42 positive genomes (P < 0.0001), 
while Clade 3 are overrepresented (P < 0.001). Additionally, 774 out of 2,432 (~32%) C. 
coli Clade 1 isolates were GT-42-positive. In C. coli Clade 1, cstVI (truncated) and cstIV 
were the most common. In contrast, cstV was the most common, and exclusively found, in 
C. coli Clade 3.  
5.2 C. coli LOS locus classes containing GT-42 encoding genes (I and III) 
Since gene content diversity is instrumental for LOS structural heterogeneity, genetic 
composition and organization of the LOS biosynthesis locus was investigated in GT-42 
positive strains. An initial mapping of all GT-42 positive genomes against known C. coli 
LOS locus classes predicted that 99% of strains positive for cstVI have a LOS locus 
resembling class III (Suppl. Table S4, Study III). Also, a large percentage of strains positive 
for cstV (93%) and cstIV (68%) were predicted to possess a LOS locus similar to LOS 
classes IX and II, respectively. No significant resemblance to previously published C. coli 
LOS locus classes was found for genomes positive for other GT-42 genes. Consequently, 
all genomes positive for cstI, cstII, cstIII, or cstVII, and a subset of randomly selected cstIV 
and cstVI positive strains (261 genomes) were assembled and manually inspected to 
potentially identify novel LOS biosynthesis locus containing GT-42 genes. Apart from cstI 
and cstVII, all GT-42 genes are found within the LOS biosynthesis locus. A total of 27 
different LOS locus classes were identified among the 160 assembled genomes found to 
contain a LOS-associated GT-42 gene. The group of LOS locus classes containing the cstII 
gene was the largest with 10 different gene content classes, followed by the cstIV (8 classes), 
cstIII (3 classes), cstV (3 classes), and cstVI (3 classes) groups (Fig. 2, Study III). Among 
the classes in the cstIII group, one was identical (100% homology) to C. jejuni LOS locus 
class C. Furthermore, sialic acid biosynthesis genes (neuABC) were present in LOS locus 
classes belonging to cstII, cstIII, and cstV LOS locus class groups, while they were absent 
in the cstIV and cstVI groups. 
5.2.1 LOS locus and C. coli clade (II and III) 
In C. jejuni, LOS locus classes are linked to population structure. To determine whether a 
similar phenomena is observed in C. coli, the distribution of GT-42 positive LOS locus 
classes between clades was investigated. A total of 11 LOS locus classes (II, III, XVI-XXIII, 
and C. jejuni LOS class C) were identified among 126 C. coli clade 1 isolates. LOS locus 
classes II and III were the most common accounting for 88.9% of C. coli Clade 1 isolates. 
Additionally, these LOS classes were found to be extremely conserved with ≥ 99% nt 
sequence identity over the whole locus. In contrast, 15 LOS locus classes (IX, XV, XXIII-
XXXV) were represented among 32 C. coli Clade 3 isolates. The most common LOS locus 
class in C. coli clade 3, XXV, only represented 25% of the isolates. Overall, the LOS 
biosynthesis locus of C. coli Clade 1 was significantly less diverse (P < 0.0001) than that of 
Clade 3 strains. No conclusions on Clade 2 diversity could be drawn out due to the limited 
number of strains.  
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5.3 Flow of C. coli LOS genes (II and III) 
The presence of LOS locus class XXIII in strains belonging to Clade 1 and Clade 3, and the high 
homology between C. jejuni and some C. coli GT-42 enzymes hinted at gene flow between C. 
coli clades and between species Therefore, gene flow between C. coli clades and between C. coli 
and C. jejuni, was assessed.  
5.3.1 Gene flow between C. coli clades (III) 
C. coli isolates belonging to different clades were found to share LOS-associated 
orthologues according to orthologue group delineation by Roary (>95% amino acid identity) 
(Fig. 3, Study III). The vast majority of the shared orthologues were predicted to encode 
proteins putatively involved in sugar biosynthesis or sugar modification (Table 3, Study III). 
Also, cstII and cstVI orthologues were found to be shared between C. coli Clade 1 and Clade 
3.  
5.3.2 Gene flow between C. coli and C. jejuni (II and III) 
The impact of introgression between C. jejuni and C. coli on the LOS biosynthesis locus 
was investigated. In previously published LOS locus classes, comparison of individual gene 
descriptions and subsequent analysis of tree topology indicated that interspecies gene 
transfer had only occurred in waaV (Fig. 2, Study II). However, amidst the identification of 
novel C. coli LOS locus classes, gene flow from C. jejuni to C. coli between the two species 
was detected in various instances. First, a high sequence similarity was observed between 
C. coli and C. jejuni cstII-associated LOS locus classes. Second, C. coli LOS classes XVI, 
XVII, XVIII, XIX, XX, XXI, and XXII were found to be a mosaic of C. jejuni LOS classes 
A, B, S/F, and I/D. Third, C. coli LOS class XXIV contains GT42 and neuB1 orthologues 
characteristic of C. coli and C. jejuni (i.e. cstV, cstII). Finally, a C. coli strain was found to 
possess a C. jejuni LOS locus class C, evidencing cross-species mobilization of the entire 
LOS biosynthesis locus.  
To assess whether gene flow of GT-42 genes was monodirectional (C. jejuni→C. coli) or 
bidirectional (C. jejuni↔ C. coli), a total of 12 391 raw genome sequences deposited as C. 
jejuni were mapped against the 7 C. coli GT-42 groups. Of the 7 577 putative C. jejuni 
genomes positive for at least one GT-42 gene, 95.75% contained either a cstII or a cstIII. 
Genes cstIV (101 genomes), cstVI (211), and cstVII (2) were present in a small fraction of 
the population, while cstV was not detected. To inspect the LOS locus composition of 
isolates positive for cstIV, cstVI, and cstVII, genomes were assembled and the species was 
verified. Surprisingly, solely 16.6% of the genomes were confirmed as C. jejuni, the rest 
were either C. coli or a mixture of both species. Among the verified C. jejuni; 40 were 
positive to cstIV, 10 to cstVI, and 2 to cstVII. Like in C. coli, cstIV and cstVI were LOS 
associated, while cstVII was located outside the LOS locus. Additionally, the LOS loci of 
87.5% of the cstIV positive C. jejuni genomes were 99% identical to C. coli LOS class II, 
demonstrating the occurrence of gene flow from C. coli to C. jejuni. 
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5.4. Origin of LOS locus classes II and III (III) 
Recognition of gene flow between C. coli Clades, and the apparent absence of other LOS 
locus classes containing cstIV or cstVI in C. coli Clade 1 LOS, incited a search for the origin 
of the most abundant LOS locus classes in C. coli Clade 1; II and III. LOS locus class II 
exhibited ~88% nucleotide identity over ~99% of length with LOS locus class XXXIV 
found in Clade 3 (Fig. 4).  
 
Fig. 4 ACT comparison LOS locus class II (top) vs LOS locus class XXXIV (bottom). 
Similarly, LOS locus class III shares high sequence similarity (>90%) with LOS locus 
classes XXVII and XXVIII found in Clade 3 (Fig. 5 and 6) over the terminal part of the 
locus.  
 
Fig. 5 ACT comparison LOS locus class III (top) vs LOS locus class XXVII (bottom) 
 
 
Fig. 6 ACT comparison LOS locus class III (top) vs LOS locus class XXVIII (bottom) 
 
Interestingly, while the putative phosphoethanolamine transferase genes (eptC) and the 
cstVI in Clade 3 encode full proteins, these genes underwent pseudogenization in Clade 1. 
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Thus, implying that LOS locus classes II and III presumptively originated in C. coli Clade 
3.   
5.5 LOS locus class groups and source of isolation (II and III) 
As results suggested that C. coli LOS locus classes II and III might have undergone 
diversification as a consequence of adaptation to the agricultural niche, the distribution of 
GT-42 positive LOS locus class groups by source of isolation was investigated in isolates 
for which metadata was available. Results are shown on Figure 7.  
 
Figure 7. Source-LOS locus class association. Circus diagram showing the distribution of LOS 
locus classes of C. coli strains isolated from different sources. Ribbon ends represent links between 
source and LOS locus class, while the width of the ribbon correlates with percentage of strains 
belonging to a certain LOS locus class from a particular source. Segments in the outer ring indicate 
the percentage of strains representing a certain LOS locus class or source of isolation, while the 
inner ring indicates the number of strains. Agricultural strains (Agri) are shown in red, clinical 
strains in dark orange, and environmental strains (Enviro) in light orange.  
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As expected, LOS locus classes II and III were dominant among agricultural isolates. 
Conversely, a small proportion of strains carrying a LOS locus class II (4.4%) or III (7.5%) 
were isolated from the environment. Although the number of strains was small, other LOS 
locus classes containing either cstIV or cstVI were not found in agricultural isolates. Seven 
strains carrying LOS locus classes XXIII, XXV XXVI, or XXVII, were also isolated from 
agricultural settings. Surprisingly, three of these strains belonged to C. coli Clade 3.  
5.6 CstIV and CstV (I, II, IV) 
The link between LOS-associated GT-42 encoding genes and LOS sialylation has only been 
established for cstII and cstIII, so far. However, the presence of other GT-42 genes among 
clinical isolates instigated research on the potential association between these genes and 
LOS structure. As cstVI is generally found as a pseudogene, efforts were focused on 
elucidating the role of cstIV and cstV in LOS biosynthesis. C. coli 65 and 73 (LOS locus 
class II, cstIV) and C. coli 76339 (LOS locus class IX, cstV) were selected as model strains 
5.6.1 Enzymatic activity (IV) 
Given that all GT-42 proteins characterized to date are sialyltransferases, the ability of 
CstIV and CstV to transferring Neu5Ac was tested. Crude protein extracts of C. coli 65, 73, 
and 76339 were tested for sialyltransferase activity in vitro using BDP or FCHASE labelled 
sugar acceptors. C. coli 76339 WT, C. coli 76339 ∆cstV-SF1, and C. coli 76339 ∆cstV-SR4 
crude protein extracts exhibited monosialyltransferase activity on BDP-Lactose (BDP-Lac) 
and BDP-N-acetyllactosamine (BDP-LacNAc) (Suppl. Fig. 1, Study IV). However, 
sialyltransferase activity was undetectable on any of the tested acceptors in the crude protein 
extracts of C. coli 76339∆cstI-XR3 and C. coli 76339∆cstV-SR∆cstI-XR1. Therefore 
detected monosyltransferase activity in C. coli 76339 WT protein extracts was due to 
presence of CstI. Similarly, no sialyltransferase activity was detected in the crude protein 
extracts of C. coli 65 and 73, C. coli 65 ∆cstIV-SF5 and C. coli 73 ∆cstIV-SF3. 
Since cstIV and cstV were confirmed to be expressed in the tested strains, it was 
hypothesized that the concentration of CstIV and CstV in the protein extracts was too low 
to be able to detect sialyltransferase activity. Consequently, CstIV and CstV were produced 
as recombinant proteins in E. coli and tested for sialyltransferase activity. Despite different 
strategies for increasing protein solubility, facilitating disulphide formation, encouraging 
protein folding, and increasing overall protein yield, none of the tested recombinant CstIV 
and CstV showed activity on any of the tested acceptors. 
5.6.2 Role in C. coli LOS biosynthesis (I and IV) 
Since the LOS of C. coli 65, 73, and 76339 was insensitive to neuraminidase, potentially 
suggesting the absence of Neu5Ac (Suppl. Fig. 4, Study IV), mutational studies were 
performed to determine whether CstIV and CstV were involved in LOS biosynthesis. 
Deletion of cstV in C. coli 76339 and cstIV in C. coli 65 and 73 resulted in LOS truncation 
(Fig. 1, Study IV). This implied that cstV in C. coli 76339, and cstIV, in C. coli 65 and 73, 
are involved in LOS biosynthesis. 
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To investigate whether CMP-Neu5Ac is CstV substrate, neuB1 was knocked out. The LOS 
of cstV and neuB1 mutants showed a similar truncation, hence, suggesting the potential 
involvement of neuB1 in CstV substrate synthesis. Analysis by HPAEC-PAD and LC-MS 
detected the presence of Neu5Ac in C. coli 76339 LOS. Furthermore, comparison of the 
predicted LOS compositions of C. coli 76339 WT and the cstV mutant showed the loss of 
Neu5Ac. Thus, establishing the association between cstV and NeuAc.  
5.6.3 Exploring CstIV substrate (II-IV) 
While the presence of Neu5Ac was confirmed in C. coli 76339, no evidence of sialylation 
was found in C. coli 65 and 73 by EA-OTLC-MS. However, further analysis by LC-MS 
suggested the presence of a diNAc-nonulosonate with a mass consistent with that of 
Leg5Ac7Ac or Pse5Ac7Ac. Comparison of the predicted LOS compositions of C. coli 73 
WT and the cstIV mutant showed the loss of the diNAc-nonulosonate residue. Hence, 
implying that cstIV is associated to the diNAc-nonulosonate residue. LOS locus class II does 
not contain any homologues known to be involved in nonulosonic acid biosynthesis. 
Additionally, genome-wise analysis did not identify genes overrepresented in LOS locus 
class II strains that might potentially be involved carbohydrate biosynthesis. However, 
legionaminic (neuB2) and pseudaminic (neuB3) synthetases are found within the conserved 
flagella glycosylation system. Thus, the role of these genes in the synthesis of CstIV 
substrate was investigated. No difference in the electrophoretic profiles C. coli 73 WT and 
C. coli 73∆neuB2 LOS was observed, implying that neuB2 is not associated to the synthesis 
of CstIV substrate. Despite repeated attempts, no C. coli 73∆neuB3 mutants were obtained. 







As a result of being major cell surface components, glycoconjugates have a considerable 
impact on host-pathogen interactions, and thus in the ecology and evolution dynamics of 
bacteria (4, 5, 92, 94, 95). Expression of host-like glycans generally facilitates evasion of 
the human immune system by pathogens (214, 286). However, recognition of C. jejuni 
ganglioside-like LOS as an antigen may result in the production of self-reacting antibodies 
and development of GBS (11, 33-35, 38, 40, 41) 
Approximately 58% of C. jejuni genomes available in public repositories (at the time of 
analysis, Study III) contain genes associated to biosynthesis and transfer of sialic acid to 
the LOS chain (186, 230, 286). Despite being isolated from GBS patients in few instances 
(13-16) and the pervasive introgression with C. jejuni, no C. coli containing the required 
molecular machinery for LOS sialylation has been described until now (17). The clinical 
strain 76339 was the first C. coli reported to possess a LOS locus containing a GT-42 gene 
(cstV) upstream of sialic acid biosynthesis genes. Thus, C. coli 76339 LOS locus partially 
resembled C. jejuni LOS locus classes A and B (Study I) (17, 175, 186). Typing of a large 
strain collection indicated that C. coli 76339 LOS locus was rare (Study II). Yet, a 
systematic search of all publicly available C. coli genomes showed that the cstVneuBCA 
gene cluster is restricted to LOS locus classes exclusively detected in C. coli Clade 3 strains 
(Study III). Thus, the apparent singularity of C. coli 76339 LOS locus was due to the 
overrepresentation of agricultural strains from Clade 1 in the isolate collection (Study II). 
In addition to cstV, six novel GT-42 homologues were identified in the study herein (Study 
I and III), showing that C. coli possess a larger GT-42 enzyme repertoire than C. jejuni (17, 
175, 186). Only two GT-42 orthologues, cstI and cstVII, are located outside the LOS 
biosynthesis locus in all the studied genomes (Study III). As previously observed for C. 
jejuni cstI, GT-42 genes located outside the LOS biosynthesis locus are unlikely to have an 
impact in LOS biosynthesis (96). Supporting this assumption, deletion of cstI in C. coli 
76339 had no effect on LOS biosynthesis (Study IV).  
Although glycan structure is not template driven, C. jejuni strains carrying LOS associated 
neuABC and cstII or cstIII have been shown to rarely synthesize non-ganglioside sialylated 
LOS (7-10). Thus, these genes are utilized as markers for recognizing C. jejuni strains 
potentially expressing ganglioside mimics (9, 10, 179). The presence of neuABC genes in 
LOS locus classes containing cstII and cstIII, hinted at the possibility of ganglioside 
mimicry in C. coli (Study III). Backing this notion, a complete C. jejuni LOS class C was 
discovered in C. coli strain SRR5152313 (100% homology). Hence, this strain may 
synthesize a GM1a- or GM2-like LOS (9). 
Originally hypothesized to be unaffected by introgression (66), phylogenetic analysis of 
previously published LOS locus genes confirmed limited genetic exchange between C. 
jejuni and C. coli (Study II). Among the identified shared orthologues, only waaV in LOS 
locus class II exhibited some evidence of recombination. However, the presence of cstII and 
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cstIII in the LOS biosynthesis locus of various C. coli strains implied that some LOS locus 
classes have arisen as consequence of introgression. Although further studies are required, 
results obtained in Study II and III indicate that only GT-42 containing LOS locus classes 
appear to be subjected to extensive recombination. In fact, all 10 C. coli LOS locus classes 
containing a cstII are mosaics of C. jejuni LOS classes (Study III). This indicates that 
genetic factors associated to ganglioside mimicry can cross species barriers. Additionally, 
the presence of cstII containing LOS locus classes XV, XXIII, and XXIV in C. coli Clade 
3 isolates points at the potential transfer of these factors across clades.   
Given the number of strains found to carry a C. jejuni-like LOS, it appears that the frequency 
at which HGT occurs is low. Overall, strains likely to express sialylated LOS are a minority, 
1.8%, among sequenced C. coli strains. Yet, this seeming rarity might be a consequence, in 
part, of sampling bias. Despite the relative low frequency, these data clearly suggest that the 
participation of C. coli in the GBS aetiology cannot be excluded. Moreover, it is worth 
noticing that even though only 3.2% of the currently known C. coli genomes belong to Clade 
3, the molecular machinery involved in the synthesis of sialylated LOS structures (i.e. 
neuABC and GT-42 genes) is strongly associated with this lineage. In contrast, the sialic 
acid biosynthesis locus is rarely found in Clade 1 GT-42 positive strains.  
The genes cstIV and cstVI are the most common GT-42 encoding genes among sequenced 
C. coli strains. Additionally, these GT-42 genes are exclusively found in LOS locus classes 
lacking the sialic acid biosynthesis genes: II and III, respectively. The LOS locus classes II 
and III are the most common LOS locus classes among sequenced C. coli strains. Despite 
being most likely originated from non-agriculture Clade 3 LOS classes, LOS locus classes 
II and III are restricted to strains belonging to the agricultural-adapted Clade 1 (Study III). 
During the process of evolution from Clade 3, in both LOS class II and III, various genes 
have undergone pseudogenization. Loss of activity, such as in the case of eptC in class II or 
cstVI in class III, may have impacted LOS structure and composition. Diversification of 
surface structures as a consequence of natural selection is common in microbial evolution. 
For instance, antigenic shift is a successful mechanism through which Neisseria 
meningitidis circumvents vaccine-induced protective immunity. As a result, immunization 
campaigns may select for capsular switching to serogroups not cover by the polysaccharide 
vaccine (287-289). Similarly, structural variability in C. jejuni capsule influence phage 
infectivity. Thus, phage predation in the avian gut has resulted in the so-call ‘Red Queen’ 
effect; evasion of rapidly evolving pathogens by altering glycan expression, without 
compromising survival (290, 291).  
The pseudogenization observed in the two most frequently detected LOS locus classes in 
Clade 1 might be the result of the recent clonal expansion of agriculture adapted population 
(Study III). In fact, C. coli clade evolution has been shaped by the introduction of the 
agricultural niche (64). A plausible evolutionary scenario for the LOS locus classes 
containing cstIV or cstVI is that adaptation to the agricultural niche caused a change in 
selective pressure. As a result, glycan structures associated to LOS locus classes II and III 
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might have provided a competitive advantage. This scenario is supported by three 
observations: (i) the predominance of LOS locus classes II and III in C. coli Clade 1 strains, 
(ii) the limited nucleotide variability in these LOS locus classes (>99% identity), hinting a 
strong purifying selection, and (iii) the presumable absence of LOS locus classes II and III 
in the environmentally associated C. coli Clades 2 and 3. Moreover, the hypothesis of LOS 
locus classes II and III playing a key role in adaptation to the agricultural niche is also 
backed by the presence of these genetic elements in the bovine associated C. jejuni ST-459 
(292). Nevertheless, further investigation is required to ascertain the role of structures 
associated to LOS locus classes II and III in niche adaptation.  
Adaptation of C. coli Clade 1 to specific animal niches might be linked to the high-affinity 
interactions between the oligosaccharide moiety in the LOS and host glycans, as previously 
suggested (5). Indeed, distribution of C. coli LOS locus classes groups among sources of 
isolation vastly reflects strain affiliation (Study II and III; (17)). For example, strains 
possessing non-GT-42 LOS locus classes VI and X were predominantly isolated from pigs, 
which is known to be frequently colonized by C. coli (Study II; (293)). However, both of 
these classes are rarely detected in humans. In the case of clinical isolates, the GT-42 
containing LOS locus classes II and III were the most common (Study II). These classes 
were also detected in multiple animal species (i.e. porcine, poultry and bovine) (Study II), 
suggesting the generalist nature of strains possessing these features and their importance in 
human disease. 
Given their potential significance for the pathogenicity and ecology of C. coli, the role of 
CstV (class IX) and CstIV (class II) in LOS biosynthesis was further explored (Study IV). 
Although the presence of Neu5Ac was initially detected in C. coli 76339 purified LOS by 
HPAEC-PAD (Study I), the occurrence of a secondary active monosyltransferase, CstI 
(Study IV), could not rule out the possibility of contamination with a non-LOS sialylated 
glycan.  
Identical LOS electrophoretic profiles were observed upon deletion of neuB or cstV, 
suggesting a similar truncation in the LOS structure, and the possible involvement of neuB 
in the synthesis of CstV substrate. According to LC-MS analysis, deletion of cstV results in 
the loss 2 Hex and 1 NeuAc. C. coli 76339 LOS is neuraminidase resistant, implying that a 
Neu5Ac is internally located in the LOS, as seen in C. jejuni 11168 (206). Consequently, 
absence of Neu5Ac could potentially impede further extension of the oligosaccharide chain.  
Attempts at confirming CstV activity in vitro were unsuccessful. Transcriptomic analysis 
of C. coli 76339 revealed the expression of LOS biosynthesis genes in a polycistronic 
fashion, confirming the active expression of cstV. However, upon deletion of cstI, no 
sialyltransferase activity was detected in C: coli 76339 protein extracts. Thus, it was 
hypothesized that the absence of detectable activity was a consequence of a low 
concentration of CstV in C. coli 76339 protein extracts. Despite numerous efforts and 
various protein expression strategies, no detectable activity on any of the tested acceptors 
was exhibited by recombinant CstV. Taken together, cstV is associated to C. coli 76339 
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LOS sialylation. However, whether cstV is involved in the synthesis of human-like glycans 
remains an open question. As a result, further studies are required to identified CstV natural 
acceptor and corroborate its activity in vitro.  
An initial analysis of crude LOS samples from various strains expressing cstIV (LOS class 
II) failed to detect Neu5Ac (Study II). LOS asialylation was concordant with rare presence 
of Neu5Ac biosynthesis genes in strains carrying cstIV (Study III). Like in cstV, no 
sialyltransferase activity was detected in the protein extracts of two LOS locus class II 
strains (C. coli 65 and 73) nor in recombinant CstIV despite several attempts. Consequently, 
CstIV appeared to be a cryptic, possibly inactive, sialyltransferase with no role in LOS 
biosynthesis. Surprisingly, deletion of cstIV in C. coli 65 and 73 resulted in LOS truncation. 
Analysis of CstIV amino acid sequence revealed numerous substitutions at conserved 
positions in characterized GT42 sialyltransferases. Moreover, substitutions of amino acids 
involved in substrate interactions, particularly with the Neu5Ac, were observed upon 
superimposition of CstIV on C. jejuni CstII (118, 119, 232, 294). Alignment of multiple 
CstIV confirmed the conservation of these substitutions. Based on these results, the 
possibility of an alternative sugar donor for CstIV was considered. While no insights into 
genes linked to the synthesis of CstIV substrate were gained by genome-wise analysis 
(Study III), detection of a diNAc-nonulosonate residue in C. coli 73 WT LOS and its 
absence in the cstIV mutant suggested neuB2 (ptmC, legI) and neuB3 (pseI) as potential 
candidates. The neuB2 (ptmC, legI) and neuB3 (pseI) encodes a legionaminic acid and a 
pseudaminic acid synthetase, respectively. In C. coli, these conserved genes are associated 
to the post-translational modification of flagellin with nonulosonic acids (131, 136-138, 
211, 230, 295). C. coli 73 ∆neuB2 expressed a LOS with a similar molecular weight as the 
WT, implying that neuB2 has no role in LOS biosynthesis. While deletion of neuB3 has 
been successful in C. coli VC167, no viable C. coli 73 ∆neuB3 mutants were obtained 
despite repeated attempts (137). It is hypothesized that flagellin glycosylation and perhaps 
LOS truncation may be lethal for C. coli 73. In summary, cstIV is associated with the 
presence of a diNAc-nonulosonate residue in C. coli 73 LOS. Although further studies are 
required to determine the nature of this residue, these results highlight the importance of 
functional studies, as divergent evolution can result in genes encoding proteins with 




7 CONCLUSIONS  
1. C. coli LOS locus classes are more diverse than previously thought. The 35 C. coli 
LOS locus classes, including the 26 identified in this study, represent a fraction of 
the LOS locus classes found in the C. coli population. Further identification of novel 
LOS locus classes will deem the current LOS class classification system results 
impractical. Grouping of LOS locus classes by their association to distinctive 
structural features, for example Neu5Ac or Qui3NAcyl would result more valuable. 
However, this would require extensive functional and structural studies.  
2.  Marked differences in the genetic diversity of the LOS locus was observed between 
C. coli Clade 1 and C. coli Clade 3. The vast majority of C. coli Clade 3 strains 
possessed a unique LOS locus class. Additionally, these classes generally contain 
the required genetic machinery for the expression of sialylated LOS structures. 
Conversely, over 80% of C. coli clade 1 strains possess a LOS locus class II or III, 
which lack the sialic acid biosynthesis genes. As a result, the LOS of C. coli Clade 
1 strains is rarely sialylated. Overall, the observed genetic differences are possibly a 
reflection of host adaptation.  
3. LOS genes can cross clade and species barriers. Several orthologues common to all 
C. coli clades were identified. More importantly, bacterial factors implicated in GBS 
aetiology have been acquired from C. jejuni and can potentially spread across the C. 
coli population, as demonstrated by the presence of cstII and cstIII in all three C. 
coli clades. Consequently, participation of C. coli in the GBS aetiology cannot be 
excluded. 
4. C. coli presents a larger GT-42 enzyme repertoire than C. jejuni. CstV is a native C. 
coli Clade 3 sialyltransferase, while CstIV is associated to the addition of a diNAc-
nonulosonate residue to the LOS chain. Based on the frequency of these genes in C. 
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